Threadlinqs IntelligenceStart free

Vendor2 products tracked

CGM vulnerabilities & exploitation

As of 2026-11-19, Threadlinqs tracks 14 CGM CVEs, 0 in the CISA Known Exploited Vulnerabilities catalog, linked to 1 tracked threat campaign.

CVEs
14Since 2025
CISA KEV
00% of CVEs
Critical
6CVSS v3 9.0+
Avg CVSS
8.3/10Max 9.4
Threats
1Linked campaigns
Actors
0None attributed

Data as of:

Exploitation timeline

Threadlinqs has recorded 14 CGM CVEs published between and . The busiest month was 2026-10 (11 new CVEs). None of them is listed in CISA KEV yet.

Most exploited vulnerabilities

Ranked with CISA KEV listings first, then EPSS exploit probability, then CVSS score. Showing 14 of 14 tracked CGM CVEs.

Products affected

Threadlinqs normalises CPE and CNA product records across all 14 CVEs; 2 distinct CGM products are affected. The most frequently affected:

  • CLININET 13 CVEs
  • NETRAAD 1 CVE

Threat activity

1 tracked threat campaign reference CGM products or exploit CGM CVEs:

How to prioritise CGM patching

This order follows the data Threadlinqs holds for CGM, not a generic severity checklist:

  • No CGM CVE is in CISA KEV yet, so rank by exploit probability instead.
  • Outside KEV, the highest EPSS scores are CVE-2025-58403 (0.5%), CVE-2025-30047 (0.4%), CVE-2025-30053 (0.4%).
  • 6 CVEs score Critical and 5 High on CVSS v3 (maximum 9.4, average 8.3); sequence these after KEV and high-EPSS items.

About this data

Vendor attribution comes from the CNA and CPE product records of each CVE, folded to one vendor name; CVSS, EPSS and KEV status are read from the Threadlinqs CVE catalog; campaign and actor links come from tracked threat records. Counts reflect the data as of 2026-11-19 and refresh daily.